Operational status of the superconducting system for LHD

Large Helical Device (LHD) is a heliotron-type experimental fusion device which has the capability of confining current-less and steady-state plasma. The primary feature on the engineering aspect of LHD is using superconducting (SC) coils for magnetic confinement: two pool boiling helical coils (H1, H2) and three pairs of forced-flow poloidal coils (IV, IS, OV). These coils are connected to the power supplies by SC bus-lines. Five plasma experimental campaigns have been performed successfully in four years from 1998. The fifth operation cycle started in August 2001 and finished in March 2002. We have succeeded to obtain high plasma parameters such as 10 keV of electron temperature, 5 keV of ion temperature and beta value of 3.2%. The operational histories of the SC coils, the SC bus-lines and the cryogenic system have been demonstrating high reliability of the large scale SC system. The operational status and the results of device engineering experiments are summarized

Stable long-term operation of superconducting current-feeder system for the LHD

A superconducting (SC) current-feeder system is used as the current transmission lines for the experimental fusion device, LRD. It consists of nine flexible SC bus lines with total length of 497 m, and nine pairs of gas-cooled current leads. To avoid the propagation of the ice on the leads, the temperature of the terminals had been kept in the range between 5 and 20 degrees C by the heaters. The measured voltage drops of all leads were less than 20 mV. The liquid helium levels of the leads and the sub-cooler tank will equalize by the siphon method. The total time of the coil excitations exceeds 3000 hours. We have demonstrated successfully that the SC current-feeder system was stable and easy to handle, and is useful for the SC experimental fusion device

First Cool-Down Performance of the LHD

The first cool-down test of the Large Helical Device (LHD) and the performance of the LHD cryogenic system during the first cycle operation are described. The first cool-down started on Feb. 23, 1998 and finished on Mar. 22. After the cool-down, the excitation tests of the SC coils up to 1.5 T and the first cycle operations for plasma physics experiments were conducted until May 18. The first cycle operation was successfully completed after the warm-up process to room temperature from May 19 to Jun. 15. The cooling characteristics of the LHD, such as temperature distribution during cool-down, heat loads under steady state condition, reliability during long-term operation, are reporte

Primary omental Gastrointestinal stromal tumor (GIST)

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Clear cell carcinoid tumor of the distal common bile duct

BACKGROUND: Carcinoid tumors rarely arise in the extrahepatic bile duct and can be difficult to distinguish from carcinoma. There are no reports of clear cell carcinoid (CCC) tumors in the distal bile duct (DBD) to the best of our knowledge. Herein, we report a CCC tumor in the DBD and review the literature concerning extrahepatic bile duct carcinoid tumors. CASE PRESENTATION: A 73-old man presented with fever and occult obstructive jaundice. Ultrasonography, computed tomography (CT) and magnetic resonance cholangiopancreaticography (MRCP) demonstrated a nodular tumor projection in the DBD without regional lymph node swelling. Under suspicion of carcinoma, we resected the head of the pancreas along with 2(nd )portion duodenectomy and a lymph node dissection. The surgical specimen showed a golden yellow polypoid tumor in the DBD (0.8 × 0.6 × 0.5 cm in size). The lesion was composed of clear polygonal cells arranged in nests and a trabecular pattern. The tumor invaded through the wall into the fibromuscular layer. Immunohistochemical stains showed that neoplastic cells were positive for neuron-specific enolase (NSE), chromogranin A, synaptophysin, and pancreatic polypeptide and negative for inhibin, keratin, CD56, serotonin, gastrin and somatostatin. The postoperative course was uneventful and he is living well without relapse 12 months after surgery. CONCLUSION: Given the preoperative difficulty in differentiating carcinoid from carcinoma, the pancreaticoduodenectomy is an appropriate treatment choice for carcinoid tumors located within the intra-pancreatic bile duct